Blue Owl Capital Holdings LP
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 15, 2025), Blue Owl Capital Holdings LP reported 45 stock positions worth $309.2 million. Its top holding was Nuveen Churchill Direct Lend (NCDL) at 22.2% of the portfolio, followed by Blue Owl Capital (OBDC, 9.7%) and Cullinan Therapeutics (CGEM, 6.0%). Compared with Q4 2024, it opened 7 new positions, sold out of 10, added to 17 and reduced 4. The biggest buy was a new position in Proshares Ultrapro QQQ (TQQQ) and the biggest sale an exit from Klaviyo Class A (KVYO).
- Most Recent 13F
- Q2 2026
- Location
- New York, NY
- CIK
- 0001858703
- Portfolio Value
- $309.2M (Q1 2025)
- SEC Filing
- 0000950123-25-005588 ↗ filed May 15, 2025
Holdings Value
Holdings 45 stocks · $309.2M
| NCDL Nuveen Churchill Direct Lend | 22.18% | 4,039,553 | $68.6M | No change |
| OBDC Blue Owl Capital Corp. | 9.69% | 2,045,070 | $30.0M | No change |
| CGEM Cullinan Therapeutics Inc. | 5.96% | 2,435,972 | $18.4M | Add +2.7% |
| EVCM Evercommerce Inc. | 5.35% | 1,641,929 | $16.6M | No change |
| TRML Tourmaline Bio Inc. | 5.10% | 1,037,107 | $15.8M | Reduce -3.9% |
| CNDT Conduent Inc. | 4.97% | 5,697,450 | $15.4M | Add +1.3% |
| ENGN Engene Holdings Inc. | 4.75% | 3,279,378 | $14.7M | Add +3.8% |
| HLLY Holley Inc. | 4.42% | 5,318,040 | $13.7M | Add +77.8% |
| LRMR Larimar Therapeutics Inc. | 3.32% | 4,778,040 | $10.3M | Add +2.7% |
| TQQQ Proshares Ultrapro QQQ | 3.24% | 175,000 | $10.0M | New |
| CVEO Civeo Corp. | 2.59% | 348,226 | $8.0M | New |
| IRON Disc Medicine Inc. | 2.25% | 140,260 | $7.0M | Add +16.6% |
| ELDN Eledon Pharmaceuticals Inc. | 2.00% | 1,819,912 | $6.2M | Reduce -7.1% |
| CMPX Compass Therapeutics Inc. | 1.82% | 2,954,712 | $5.6M | No change |
| RARE Ultragenyx Pharmaceutical Inc. | 1.79% | 153,238 | $5.5M | Add +29.6% |
| IKENA ONCOLOGY INC | 1.69% | 4,091,118 | $5.2M | No change |
| CNTA Centessa Pharmaceuticals Ltd. | 1.46% | 315,000 | $4.5M | Add +43.2% |
| CNTX Context Therapeutics Inc. | 1.46% | 7,367,906 | $4.5M | Add +15.9% |
| SGMT Sagimet Biosciences Inc. Class A | 1.40% | 1,328,351 | $4.3M | Add +0.3% |
| EYPT Eyepoint Inc. | 1.40% | 797,594 | $4.3M | Add +19.5% |
| PLRX Pliant Therapeutics Inc. | 1.30% | 2,969,199 | $4.0M | Add +7.2% |
| PVLA Palvella Therapeutics Inc. | 1.27% | 140,259 | $3.9M | Reduce -43.9% |
| RPTX Repare Therapeutics Inc. | 1.10% | 3,443,659 | $3.4M | No change |
| ETWO E2OPEN Parent Holdings Inc. | 1.07% | 1,650,943 | $3.3M | No change |
| MLYS Mineralys Therapeutics Inc. | 1.06% | 206,296 | $3.3M | New |
| CMPS Compass Pathways PLC | 1.05% | 1,135,828 | $3.2M | Add +604.4% |
| TNGX Tango Therapeutics Inc. | 0.94% | 2,121,652 | $2.9M | Add +22.5% |
| KROS Keros Therapeutics Inc. | 0.88% | 266,033 | $2.7M | Add +9.6% |
| AQST Aquestive Therapeutics Inc. | 0.86% | 920,000 | $2.7M | Add +2.2% |
| NN Nextnav Inc. | 0.78% | 198,760 | $2.4M | New |
| GATE Marblegate Acquisition Cor-A | 0.44% | 91,429 | $1.4M | No change |
| VRNA Verona Pharma Ltd. | 0.38% | 18,347 | $1.2M | New |
| EPD Enterprise Products Partners | 0.35% | 31,290 | $1.1M | No change |
| ADCT Adc Therapeutics SA | 0.33% | 733,568 | $1.0M | No change |
| INZY Inozyme Pharma Inc. | 0.32% | 1,080,027 | $983K | No change |
| GOCOQ Gohealth Inc. Class A | 0.22% | 25,096 | $694K | Reduce -69.9% |
| MRKR Marker Therapeutics Inc. | 0.22% | 554,250 | $682K | No change |
| ALPHA MODUS HLDGS INC | 0.15% | 394,078 | $454K | New |
| ROIV Roivant Sciences Ltd. | 0.13% | 39,003 | $394K | No change |
| SHFS SHF Holdings Inc. | 0.11% | 75,897 | $326K | No change |
| CAH Cardinal Health Inc. | 0.08% | 1,718 | $237K | No change |
| RZLV Rezolve AI PLC | 0.07% | 181,667 | $220K | No change |
| CRML Critical Metals Corp. | 0.03% | 67,718 | $94K | New |
| AEON Aeon Biopharma Inc. | 0.01% | 42,353 | $25K | Add +0.3% |
| ENGENE HOLDINGS INC | 0.01% | 36,100 | $22K | No change |
Other holdings (28): bonds, preferreds, convertibles and warrants · $837K (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| SLND.WS Legato Merger Corp. II -CW23 | *W EXP 02/14/202 | 860,302 | $138K | No change |
| NIOBW Niocorp Developments Ltd. -28 | *W EXP 03/17/202 | 766,527 | $123K | No change |
| RZLVW Rezolve AI PLC -CW27 | *W EXP 08/15/202 | 603,429 | $121K | No change |
| AMODW Insight Acquisition Co. -CW23 | *W EXP 12/13/202 | 1,854,665 | $106K | Add +56.1% |
| GATEW Marblegate Acquisition -CW22 | *W EXP 08/31/202 | 597,333 | $96K | No change |
| BKSYW Blacksky Technology -CW24 | *W EXP 09/09/202 | 350,000 | $46K | No change |
| OPTXW Omnilit Acquisition Class A -23 | *W EXP 99/99/999 | 803,132 | $40K | No change |
| BNAIW Brand Engagement Netwo -CW27 | *W EXP 03/14/202 | 1,666,808 | $33K | Add +4759.1% |
| ZAPWF Zapp Electric Vehicles -28 | *W EXP 99/99/999 | 1,930,986 | $19K | No change |
| ZEOWW Esgen Acquisition A -CW23 | *W EXP 03/13/202 | 250,000 | $15K | No change |
| RDZNW Vahanna Tech Edge -CW24 | *W EXP 11/30/202 | 225,000 | $14K | No change |
| TVGNW Semper Paratus Acqu -CW26 | *W EXP 02/14/202 | 200,000 | $10K | No change |
| PITWF Heramba Electric PLC-28 | *W EXP 07/26/202 | 989,998 | $10K | No change |
| LVWR.WS Livewire Group Inc.-27 | *W EXP 09/26/202 | 400,000 | $8K | No change |
| BDMDW Baird Medical Investment -28 | *W EXP 10/01/202 | 100,000 | $8K | No change |
| PGYWW Pagaya Technologies Ltd. -27 | *W EXP 99/99/999 | 48,661 | $7K | No change |
| NVNWF Nvni Group Ltd.-28 | *W EXP 11/01/202 | 200,000 | $6K | No change |
| VSTWF Vast Solar PTY Ltd. -28 | *W EXP 07/01/202 | 200,000 | $6K | No change |
| DAVEW Dave Inc. -CW27 | *W EXP 01/05/202 | 28,750 | $5K | No change |
| BSLKW Golden Arrow Merger A -CW26 | *W EXP 08/13/202 | 166,666 | $5K | New |
| MLKWF Waldencast Acq Class A -CW27 | *W EXP 07/27/202 | 33,333 | $4K | No change |
| BTMWQ Bitcoin Depot Inc.-CW23 | *W EXP 06/30/202 | 50,000 | $4K | No change |
| KPLTW Katapult Holdings Inc. -CW26 | *W EXP 06/09/202 | 400,000 | $4K | No change |
| ASBPW Aspire Biopharma Holdin-CW27 | *W EXP 02/14/203 | 50,000 | $4K | New |
| ZCARW Zoomcar Holdings Inc. | *W EXP 05/31/202 | 250,000 | $3K | No change |
| CEROW Phoenix Biotech Acq -CW26 | *W EXP 02/13/202 | 224,930 | $2K | No change |
| SDSTW Global Partner Acq A -CW27 | *W EXP 06/21/202 | 16,666 | $1K | No change |
| XBPEW CF Acquisition Viii A -CW27 | *W EXP 11/30/202 | 24,778 | $743 | No change |
Total filed on the 13F, all lines: $310.1M.
Portfolio Sells Q4 2024 → Q1 2025
| KVYO Klaviyo Inc. Class A | Sold out | 0.00% | −10.28 |
| GOCOQ Gohealth Inc. Class A | Reduce -69.9% | 0.22% | −2.35 |
| SLRN Acelyrin Inc. | Sold out | 0.00% | −2.02 |
| MREO Mereo Biopharma Group PL-ADR | Sold out | 0.00% | −0.54 |
| OMGAQ Omega Therapeutics Inc. | Sold out | 0.00% | −0.18 |
| GTLB Gitlab Inc. Class A | Sold out | 0.00% | −0.13 |
| OPTX Syntec Optics Holdings Inc. | Sold out | 0.00% | −0.03 |
| PLUM ACQUISITION CORP III | Sold out | 0.00% | −0.02 |
| SATX Satixfy Communications Ltd. | Sold out | 0.00% | −0.02 |
| BITCOIN DEPOT INC | Sold out | 0.00% | −0.01 |
| BYNO Bynordic Acquisition Corp. | Sold out | 0.00% | −0.00 |
| TRML Tourmaline Bio Inc. | Reduce -3.9% | 5.10% | +0.04 |
| ELDN Eledon Pharmaceuticals Inc. | Reduce -7.1% | 2.00% | +0.13 |
| PVLA Palvella Therapeutics Inc. | Reduce -43.9% | 1.27% | +0.58 |
Portfolio Buys Q4 2024 → Q1 2025
| TQQQ Proshares Ultrapro QQQ | New | 3.24% | +3.24 |
| CVEO Civeo Corp. | New | 2.59% | +2.59 |
| HLLY Holley Inc. | Add +77.8% | 4.42% | +2.33 |
| MLYS Mineralys Therapeutics Inc. | New | 1.06% | +1.06 |
| CMPS Compass Pathways PLC | Add +604.4% | 1.05% | +0.91 |
| NN Nextnav Inc. | New | 0.78% | +0.78 |
| RARE Ultragenyx Pharmaceutical Inc. | Add +29.6% | 1.79% | +0.64 |
| CNTA Centessa Pharmaceuticals Ltd. | Add +43.2% | 1.46% | +0.61 |
| IRON Disc Medicine Inc. | Add +16.6% | 2.25% | +0.49 |
| VRNA Verona Pharma Ltd. | New | 0.38% | +0.38 |
| EYPT Eyepoint Inc. | Add +19.5% | 1.40% | +0.25 |
| ALPHA MODUS HLDGS INC | New | 0.15% | +0.15 |
| AQST Aquestive Therapeutics Inc. | Add +2.2% | 0.86% | +0.12 |
| CRML Critical Metals Corp. | New | 0.03% | +0.03 |
| SGMT Sagimet Biosciences Inc. Class A | Add +0.3% | 1.40% | +0.02 |
| KROS Keros Therapeutics Inc. | Add +9.6% | 0.88% | −0.01 |
| CNTX Context Therapeutics Inc. | Add +15.9% | 1.46% | −0.09 |
| ENGN Engene Holdings Inc. | Add +3.8% | 4.75% | −0.11 |
| CNDT Conduent Inc. | Add +1.3% | 4.97% | −0.28 |
| TNGX Tango Therapeutics Inc. | Add +22.5% | 0.94% | −0.30 |
| AEON Aeon Biopharma Inc. | Add +0.3% | 0.01% | −0.37 |
| CGEM Cullinan Therapeutics Inc. | Add +2.7% | 5.96% | −0.71 |
| LRMR Larimar Therapeutics Inc. | Add +2.7% | 3.32% | −0.84 |
| PLRX Pliant Therapeutics Inc. | Add +7.2% | 1.30% | −7.13 |
Notes & Other Activity Q4 2024 → Q1 2025
| PLMWF Plum Acquisition Corp. III-CW | *W EXP 03/31/202 | Sold out | 1,166,665 | $220Kbefore exit |
| AMODW Insight Acquisition Co. -CW23 | *W EXP 12/13/202 | Add +56.1% | 1,854,665 | $106K |
| BNAIW Brand Engagement Netwo -CW27 | *W EXP 03/14/202 | Add +4759.1% | 1,666,808 | $33K |
| BYNOW Bynordic Acquisition -CW27 | *W EXP 07/01/202 | Sold out | 516,185 | $21Kbefore exit |
| BSLKW Golden Arrow Merger A -CW26 | *W EXP 08/13/202 | New | 166,666 | $5K |
| ASBPW Aspire Biopharma Holdin-CW27 | *W EXP 02/14/203 | New | 50,000 | $4K |
| NKGNW Graf Acquisition Corp.-CW28 | *W EXP 05/31/202 | Sold out | 30,000 | $3Kbefore exit |
| ASBPW Aspire Biopharma Holdin-CW27 | *W EXP 05/23/202 | Sold out | 50,000 | $3Kbefore exit |
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 48 | $656.7M | SPCX, AKTS, CGEM, LRMR, NCDL |
| Q1 2026 | 54 | $369.9M | AKTS, LRMR, ENGN, NCDL, CGEM |
| Q4 2025Amended | 50 | $320.9M | ENGN, NCDL, OBDC, LRMR, CGEM |
| Q3 2025 | 46 | $319.9M | NCDL, OBDC, ENGN, LRMR, EVCM |
| Q2 2025 | 46 | $308.2M | NCDL, OBDC, CGEM, EVCM, TRML |
| Q1 2025 | 45 | $309.2M | NCDL, OBDC, CGEM, EVCM, TRML |
| Q4 2024 | 48 | $432.6M | NCDL, KVYO, PLRX, OBDC, CGEM |
| Q3 2024 | 68 | $514.6M | NCDL, KVYO, TRML, PLRX, CGEM |
| Q2 2024 | 40 | $359.5M | CGEM, PLRX, OBDC, KVYO, LRMR |
| Q1 2024 | 44 | $500.6M | HOOD, CGEM, PLRX, ENGN, TRML |